- Home
- PGEN vs LPG Comparison
PGEN vs LPG Comparison
Compare PGEN & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | LPG |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PGEN | LPG |
|---|---|---|
| Price | $6.86 | $50.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $8.33 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 6.2M | 514.1K |
| Earning Date | 05-13-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 8.26% |
| EPS Growth | N/A | ★ 112.15 |
| EPS | 0.03 | ★ 3.24 |
| Revenue | $230,981,000.00 | ★ $481,511,242.00 |
| Revenue This Year | $1,115.92 | $35.73 |
| Revenue Next Year | $81.04 | N/A |
| P/E Ratio | $231.00 | ★ $15.44 |
| Revenue Growth | N/A | ★ 36.27 |
| 52 Week Low | $2.99 | $23.76 |
| 52 Week High | $7.72 | $52.10 |
Technical Indicators
Market Signals| Indicator | PGEN | LPG |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 62.47 |
| Support Level | $3.96 | $42.12 |
| Resistance Level | $7.32 | $52.10 |
| Average True Range (ATR) | 0.39 | 1.66 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 51.38 | 80.62 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.